H.R. 3 117th Congress
Elijah E. Cummings Lower Drug Costs Now Act
- Health
- Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]
- Congress.gov ↗
Latest action, Apr 27, 2021: Referred to the Subcommittee on Oversight and Investigations.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
92 cosponsors
Sponsored by Rep. Pallone, Frank, Jr. [D-NJ-6] (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
92 D · 0 R
- Democrat
- Republican
- Independent
Referred to: House: Education and Workforce Committee; House: Energy and Commerce Committee; House: Oversight and Government Reform Committee; House: Veterans' Affairs Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
60 PLUS ASSOCIATION
8 reports
AMERICA'S HEALTH INSURANCE PLANS (AHIP)
BLUESTONE STRATEGIES, LLC
8 reports
AMERICAN HOSPITAL ASSOCIATION
PLURUS STRATEGIES, LLC
8 reports
8 reports
8 reports
CENTER FOR FREEDOM AND PROSPERITY
8 reports
ELI LILLY & COMPANY
WILLIAMS AND JENSEN, PLLC
8 reports
8 reports
8 reports
HEALTHCARE INSTITUTE OF NEW JERSEY
WINNING STRATEGIES WASHINGTON
8 reports
8 reports
8 reports
NATIONAL SMALL BUSINESS ASSOCIATION
8 reports
All 25 of 317 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| 60 PLUS ASSOCIATION | 8 | $0 | Q1 2021 | Q3 2022 | yes | |
| AMERICA'S HEALTH INSURANCE PLANS (AHIP) | BLUESTONE STRATEGIES, LLC | 8 | $0 | Q1 2021 | Q3 2022 | yes |
| AMERICAN HOSPITAL ASSOCIATION | PLURUS STRATEGIES, LLC | 8 | $0 | Q1 2021 | Q3 2022 | yes |
| AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. | S-3 GROUP | 8 | $480K | Q1 2021 | Q3 2022 | yes |
| CALIFORNIA LIFE SCIENCES | 8 | $1.3M | Q1 2021 | Q3 2022 | yes | |
| CENTER FOR FREEDOM AND PROSPERITY | 8 | $0 | Q1 2021 | Q3 2022 | yes | |
| ELI LILLY & COMPANY | WILLIAMS AND JENSEN, PLLC | 8 | $0 | Q1 2021 | Q3 2022 | yes |
| EMD SERONO INC | 8 | $4.6M | Q1 2021 | Q3 2022 | yes | |
| GREATER NEW YORK HOSPITAL ASSOCIATION | 8 | $3.0M | Q1 2021 | Q3 2022 | yes | |
| GSK (FKA GLAXOSMITHKLINE INC.) | 8 | $9.8M | Q1 2021 | Q3 2022 | yes | |
| HEALTHCARE INSTITUTE OF NEW JERSEY | WINNING STRATEGIES WASHINGTON | 8 | $0 | Q1 2021 | Q3 2022 | yes |
| MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) | 8 | $2.2M | Q1 2021 | Q3 2022 | yes | |
| MERCK & CO INC | 8 | $16.3M | Q1 2021 | Q3 2022 | yes | |
| NATIONAL MULTIPLE SCLEROSIS SOCIETY | 8 | $402K | Q1 2021 | Q3 2022 | yes | |
| NATIONAL SMALL BUSINESS ASSOCIATION | 8 | $205K | Q1 2021 | Q3 2022 | yes | |
| NOVARTIS | 8 | $12.3M | Q1 2021 | Q3 2022 | yes | |
| PFIZER | WILLIAMS AND JENSEN, PLLC | 8 | $0 | Q1 2021 | Q3 2022 | yes |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 8 | $57.9M | Q1 2021 | Q3 2022 | yes | |
| PHRMA | WILLIAMS AND JENSEN, PLLC | 8 | $400K | Q1 2021 | Q3 2022 | yes |
| PLASMA PROTEIN THERAPEUTICS ASSOCIATION | 8 | $1.3M | Q1 2021 | Q3 2022 | yes | |
| THE UNIVERSITY OF CHICAGO MEDICAL CENTER | CARMEN GROUP INCORPORATED | 8 | $477K | Q1 2021 | Q3 2022 | yes |
| UNITED AUTOMOBILE AEROSPACE & AGRICULTURAL IMPLEMENT WORKERS | 8 | $1.3M | Q1 2021 | Q3 2022 | yes | |
| ACADEMY OF GENERAL DENTISTRY | KENT & O'CONNOR, INC. | 7 | $140K | Q4 2021 | Q3 2022 | yes |
| ALLINA HEALTH | PRIME POLICY GROUP | 7 | $0 | Q4 2021 | Q3 2022 | yes |
| AMERICAN LUNG ASSOCIATION | 7 | $390K | Q4 2021 | Q3 2022 | yes |